These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6218857)

  • 1. Influence of previous gold toxicity on subsequent development of penicillamine toxicity.
    Smith PJ; Swinburn WR; Swinson DR; Stewart IM
    Br Med J (Clin Res Ed); 1982 Aug 28-Sep 4; 285(6342):595-6. PubMed ID: 6218857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential gold and penicillamine therapy in rheumatoid arthritis.
    Halla JT; Cassady J; Hardin JG
    Am J Med; 1982 Mar; 72(3):423-6. PubMed ID: 6174045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole.
    Husain Z; Runge LA
    J Rheumatol; 1980; 7(6):825-30. PubMed ID: 6451692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
    Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
    Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis.
    Kean WF; Dwosh IL; Anastassiades TP; Ford PM; Kelly HG
    Arthritis Rheum; 1980 Feb; 23(2):158-64. PubMed ID: 7362666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to D-penicillamine after gold toxicity.
    Dodd MJ; Griffiths ID; Thompson M
    Br Med J; 1980 Jun; 280(6230):1498-500. PubMed ID: 6770953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    J Rheumatol; 1983 Apr; 10(2):319-22. PubMed ID: 6864688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide, gold and penicillamine--disease-modifying drugs in rheumatoid arthritis--tailored dosage and ultimate success.
    Gumpel JM
    Rheumatol Rehabil; 1976 Aug; 15(3):217-20. PubMed ID: 968355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly.
    Kean WF; Anastassiades TP; Dwosh IL; Ford PM; Kelly WG; Dok CM
    J Am Geriatr Soc; 1982 Feb; 30(2):94-100. PubMed ID: 6460054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is penicillamine therapy in rheumatoid arthritis influenced by previous treatment with gold?
    Webley M; Coomes EN
    Br Med J; 1978 Jul; 2(6130):91. PubMed ID: 667575
    [No Abstract]   [Full Text] [Related]  

  • 12. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: D-penicillamine in rheumatoid arthritis.
    Lancet; 1975 May; 1(7916):1123-5. PubMed ID: 49477
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of previous gold toxicity on subsequent development of penicillamine toxicity.
    Goldberg IJ; Lawton K; Redding JR; Francois PE; Phull J
    Br Med J (Clin Res Ed); 1982 Dec; 285(6355):1659. PubMed ID: 6814696
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The toxicity of D-penicillamine in systemic sclerosis.
    Steen VD; Blair S; Medsger TA
    Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penicillamine in rheumatoid arthritis: adverse effects.
    Hill HF
    Scand J Rheumatol Suppl; 1979; (28):94-9. PubMed ID: 156393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between aurothioglucose- and D-penicillamine-induced proteinuria.
    Speerstra F; van de Putte LB; Rasker JJ; Reekers P; Vandenbroucke JP
    Scand J Rheumatol; 1984; 13(4):363-8. PubMed ID: 6441248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP; Rasker JJ; de Rooij DJ
    J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.
    Essigman WK
    Ann Rheum Dis; 1982 Dec; 41(6):617-20. PubMed ID: 6216862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.